Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Digoxin anticorps

DIG ELISA Hôte: Souris Monoclonal unconjugated
N° du produit ABIN7212160
  • Antigène Tous les produits Digoxin (DIG)
    Digoxin (DIG)
    Reactivité
    Veuillez nous consulter SVP
    Hôte
    • 38
    • 18
    • 2
    • 1
    • 1
    Souris
    Clonalité
    • 39
    • 21
    Monoclonal
    Conjugué
    • 22
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp Digoxin est non-conjugé
    Application
    • 26
    • 22
    • 9
    • 6
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Fonction
    Digoxin Monoclonal Antibody
    Purification
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
    Immunogène
    Digoxin
    Isotype
    IgG1
  • Indications d'application
    Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: ELISA (1:10000). Not yet tested in other applications.
    Commentaires

    Primary Antibody

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
  • Antigène
    Digoxin (DIG)
    Autre désignation
    Digoxin (DIG Produits)
    Classe de substances
    Chemical
    Sujet
    Mouse Anti-Digoxin Monoclonal Antibody,Digoxin,The most common indications for digoxin are atrial fibrillation and atrial flutter with rapid ventricular response, though beta blockers and/or calcium channel blockers are a better first choice. There is tentative evidence that digoxin may increase the risk of death, though another meta-analysis reports no change in mortality. High ventricular rate leads to insufficient diastolic filling time. By slowing down the conduction in the AV node and increasing its refractory period, digoxin can reduce the ventricular rate. The arrhythmia itself is not affected, but the pumping function of the heart improves, owing to improved filling.,Digoxin
Vous êtes ici:
Support technique